U.S. Building Stock News

NYSE:TRAK
NYSE:TRAKSoftware

ReposiTrak (TRAK) Margins Hold Near 30% And Support Existing Bullish Efficiency Narratives

ReposiTrak (TRAK) has put up another steady quarter in Q2 2026, reporting revenue of US$5.9 million and basic EPS of US$0.09, with net income excluding extra items at US$1.6 million as investors weigh these figures against its recent growth track record. The company has seen quarterly revenue move from US$5.5 million in Q2 2025 to US$5.9 million in the latest quarter, while basic EPS over that span has ranged between US$0.08 and US$0.10. This is setting the stage for investors to focus on how...
NYSE:COUR
NYSE:COURConsumer Services

Coursera Udemy Combination Puts AI Growth Vision And Valuation In Focus

Coursera, NYSE:COUR, has announced an agreement to combine with Udemy. The companies plan to create a larger online learning platform with a focus on AI powered experiences. The move signals consolidation in online education and is expected to be closely watched by investors and industry participants. For investors tracking NYSE:COUR, the announcement comes after a challenging period for the share price. Coursera closed at $5.93, with a 3.3% gain over the past week but declines of 5.7% over...
NasdaqGS:ADI
NasdaqGS:ADISemiconductor

Analog Devices (ADI) Net Margin Expansion Tests Bullish Long‑Term Profitability Narratives

Analog Devices (ADI) opened its new fiscal year with Q1 2026 results that sit on top of a clear ramp in recent quarters, with revenue moving from US$2,443.2 million in Q4 2024 to US$3,076.1 million in Q4 2025 and basic EPS stepping up from US$0.96 to US$1.60 over the same period. Over the trailing twelve months to Q4 2025, total revenue reached US$11.0 billion and basic EPS came in at US$4.59. This gives investors a fuller sense of earnings power coming into this latest print and sets the...
NYSE:SMWB
NYSE:SMWBSoftware

Similarweb (SMWB) Q4 Loss Widens As Profitability Timeline Faces Bullish Narrative Test

Similarweb (SMWB) has wrapped up FY 2025 with Q4 revenue of US$72.8 million and a basic EPS loss of US$0.09, alongside net income excluding extra items of a US$7.5 million loss. The company has seen revenue move from US$65.6 million in Q4 2024 to US$72.8 million in Q4 2025, while quarterly basic EPS shifted from a US$0.07 loss to a US$0.09 loss over the same period. This sets up a story focused on how quickly margins can tighten or ease from here. See our full analysis for Similarweb. With...
NYSE:FVRR
NYSE:FVRRProfessional Services

Fiverr (FVRR) Earnings Growth And 5.2% Margin Test Bullish Profitability Narrative

Fiverr International (FVRR) just posted its FY 2025 numbers with Q3 revenue of US$107.9 million and basic EPS of US$0.15, set against trailing twelve month revenue of US$427.4 million and EPS of US$0.62 that reflect earnings growth of 121.2% over the past year. The company has seen quarterly revenue move from US$94.7 million in Q2 2024 to a range of roughly US$107 million to US$108.6 million across the first three quarters of 2025. Over the same 2025 periods, basic EPS shifted from US$0.09 in...
NYSE:ICL
NYSE:ICLChemicals

ICL Group (NYSE:ICL) Net Margin At 5.2% Tests Valuation Narratives Ahead Of Results

ICL Group (NYSE:ICL) has posted another steady quarter, with Q3 FY 2025 revenue of US$1.9 billion and basic EPS of US$0.09, supported by net income of US$115 million. Over the past few quarters, the company has seen revenue move from US$1.6 billion in Q4 FY 2024 to US$1.8 billion in Q2 FY 2025 and US$1.9 billion in Q3 FY 2025. Quarterly EPS has ranged between US$0.05 and US$0.09, setting up a results season in which investors are likely to focus closely on how resilient margins look from...
NasdaqGM:PRE
NasdaqGM:PREHealthcare

Prenetics Global (PRE) Quarterly Loss Narrows To US$5.5 Million Challenging Bearish Narratives

Prenetics Global (NasdaqGM:PRE) has just posted its FY 2025 third quarter numbers, with revenue of US$23.6 million and a basic EPS loss of US$0.40, keeping the company in loss-making territory. The company’s quarterly revenue has moved from US$10.5 million in Q4 2024 to US$17.3 million in Q1 2025, US$15.0 million in Q2 2025 and now US$23.6 million in Q3 2025. Over the same period, EPS losses have shifted from US$1.28 to US$0.80, US$0.64 and US$0.40. Investors are likely to weigh these results...
NasdaqGS:EQPT
NasdaqGS:EQPTTrade Distributors

Wall Street Backs EquipmentShare IPO Story With Growth And Valuation Upside

Wall Street brokerages have started coverage of EquipmentShare.com after its recent IPO, focusing on the company’s technology driven rental model. Analysts are highlighting EquipmentShare’s plans to expand its rental footprint and its capital light approach to fleet growth. The new coverage is drawing attention to the company’s goal of doubling rental locations and its position in the equipment rental industry. EquipmentShare.com, listed on NasdaqGS:EQPT, is coming onto more investors’...
NYSE:WAT
NYSE:WATLife Sciences

Waters Targets Growth With MaxPeak Columns And Four-Division Realignment

Waters Corporation (NYSE:WAT) introduced new high-sensitivity liquid chromatography columns featuring MaxPeak Premier Technology. The company completed a realignment of its operations into four focused divisions aimed at adjacent high-growth markets. Waters, a long-established player in analytical instruments and laboratory solutions, is using this product launch and business realignment to sharpen its role in analytical sciences and diagnostics. The new columns with MaxPeak Premier...
NasdaqGS:LBTY.A
NasdaqGS:LBTY.ATelecom

Liberty Global (LBTY.A) Quarterly Loss Narrows Yet LTM US$1.9b Loss Reinforces Bearish Narratives

Liberty Global (LBTY.A) has reported another tough set of numbers for FY 2025, with Q3 revenue of US$1,207.1 million and a basic EPS loss of US$0.27, alongside trailing 12 month revenue of US$4.8 billion and a basic EPS loss of US$5.47. Over recent periods, the company has seen revenue move from US$1,069.5 million in Q3 2024 to US$1,207.1 million in Q3 2025, while EPS has shifted from a loss of US$4.0 in Q3 2024 to a loss of US$0.27 in Q3 2025. Overall, the latest figures keep the spotlight...
NYSE:DRD
NYSE:DRDMetals and Mining

DRDGOLD (NYSE:DRD) Margin Surge To 28.5% Tests Bearish Profitability Narratives

DRDGOLD (NYSE:DRD) has put up another firm set of numbers for H1 2026, with H2 2025 revenue at R4.1b and basic EPS of R14.76 sitting on top of R1.3b in net income, while the trailing twelve month line shows revenue of R7.9b and basic EPS of R26.01 backed by R2.2b in net income. The company has seen revenue move from R3.3b in H2 2024 to R3.8b in H1 2025 and then R4.1b in H2 2025, alongside basic EPS stepping from R8.58 to R11.26 and then R14.76. This progression sets a clear earnings rhythm...
NasdaqGS:DOX
NasdaqGS:DOXIT

Amdocs (DOX) Margin Improvement To 12.5% Tests Longstanding Earnings Skepticism

Amdocs (DOX) has opened Q1 2026 with revenue of US$1.2 billion and basic EPS of US$1.46, setting the tone for investors focused on how profit is tracking against prior quarters. The company has seen quarterly revenue hold around the US$1.1 billion mark over the past year, from US$1.11 billion in Q1 2025 to US$1.16 billion in Q1 2026. Over the same period, basic EPS moved from US$1.34 to US$1.46, and trailing twelve month EPS sits at US$5.19. With net profit margins having improved over the...
NYSE:TOL
NYSE:TOLConsumer Durables

Toll Brothers (TOL) Margin Compression Challenges Bullish Luxury Housing Narratives

Toll Brothers (TOL) opened its 2026 fiscal year with Q1 revenue of US$2.1b and basic EPS of US$2.20, setting the tone for how its upscale housing demand is feeding through to the bottom line. The company has seen quarterly revenue move from US$1,859.1m and EPS of US$1.76 in Q1 2025 to US$2,145.6m and EPS of US$2.20 in Q1 2026. Trailing 12 month EPS sits at US$14.12 on revenue of US$11.3b, giving investors a clear view of scale. With a trailing net margin of 12.3% versus 14.0% last year, the...
NasdaqGS:IOSP
NasdaqGS:IOSPChemicals

Innospec (IOSP) Margin Rebound And EPS Surge Challenge Earnings Skeptics

Innospec (IOSP) has wrapped up FY 2025 with Q4 revenue of US$455.6 million and basic EPS of US$1.91, alongside trailing twelve month revenue of US$1.8 billion and EPS of US$4.69 that sit against a year of sharply higher earnings growth and a net margin of 6.6% versus 1.9% a year earlier. Over recent periods, revenue has ranged from US$439.7 million to US$466.8 million per quarter, while quarterly EPS has moved between a loss of US$2.82 and a gain of US$1.91. This sets the stage for investors...
OTCPK:ELTP
OTCPK:ELTPPharmaceuticals

Elite Pharmaceuticals (OTCPK:ELTP) Profit Turnaround Challenges Bearish Earnings Quality Narratives

Elite Pharmaceuticals (ELTP) just posted its Q3 2026 numbers, with revenue of US$31.6 million, basic EPS of US$0.017, and net income of US$18.6 million, while on a trailing twelve month basis revenue sits at US$140.1 million and EPS at US$0.040. Over the past few quarters, the company has seen revenue move between US$14.4 million and US$40.2 million per quarter, with basic EPS ranging from a loss of US$0.010 to a profit of US$0.018, and trailing twelve month EPS shifting from a loss of...
NasdaqGS:CZR
NasdaqGS:CZRHospitality

Caesars Entertainment (CZR) EPS Swing To Q4 Loss Tests Bullish Recovery Narrative

Caesars Entertainment (CZR) closed out FY 2025 with fourth quarter revenue of US$2.9 billion, a basic EPS loss of US$1.23 and a net income loss of US$250 million, compared with revenue of US$2.8 billion, basic EPS of US$0.05 and net income of US$11 million in the same quarter a year earlier. Over the past year, the company has seen quarterly revenue range from US$2.8 billion to US$2.9 billion, while basic EPS moved from a US$0.27 loss in Q3 2025 to a US$1.23 loss in Q4 2025. Trailing twelve...
NasdaqGS:MKSI
NasdaqGS:MKSISemiconductor

MKS Instruments (MKSI) Earnings Surge And Margin Expansion Test Bullish AI‑Driven Narratives

MKS (MKSI) has wrapped up FY 2025 with Q4 revenue of US$1.0b and basic EPS of US$1.60, alongside trailing twelve month revenue of US$3.9b and EPS of US$4.38 that sit against a 55.3% earnings lift over the past year. The company has seen quarterly revenue move from US$934m in Q4 2024 to US$1.0b in Q4 2025, while basic EPS shifted from US$1.35 to US$1.60 over the same period. Analysts are forecasting 27.9% annual earnings growth and higher net profit margins, keeping investor attention firmly...
NYSE:MNR
NYSE:MNROil and Gas

Mach Natural Resources Balances Integration Issues With Higher Cash Distributions

Mach Natural Resources (NYSE:MNR) is working through integration challenges tied to newly acquired oil assets in the Central Basin Platform. At the same time, the company has announced an increase in its quarterly cash distribution to unitholders. The combination of operational complexity and higher cash returns has drawn fresh attention from investors and analysts. Mach Natural Resources comes into this news with a recent unit price of $13.31 and a mixed return profile. The units are up...
NasdaqGM:NAMS
NasdaqGM:NAMSBiotechs

NewAmsterdam Expands Obicetrapib Trials Into Diabetes And Alzheimer’s As Losses Mount

NewAmsterdam Pharma has begun late stage RUBENS Phase 3 trials of obicetrapib in patients with Type 2 diabetes and metabolic syndrome. The company also plans to launch a new trial of obicetrapib in early Alzheimer's disease. These programs expand obicetrapib's potential use into major cardiometabolic and neurological conditions. For investors watching NasdaqGM:NAMS, these trial moves come as the stock trades at $35.24 and has returned 75.8% over the past year and 237.2% over the past five...
NYSE:BTGO
NYSE:BTGOCapital Markets

Is There Now An Opportunity In Bitgo Holdings (BTGO) After 41% Year To Date Share Price Fall

If you are trying to figure out whether Bitgo Holdings at around US$10.87 is a bargain or a value trap, starting with a clear view of what the current price reflects can help you frame the opportunity and the risks. The stock has seen a 1.4% decline over the last 7 days and a 41.2% decline year to date, which can change how the market views its growth potential and risk profile. Recent coverage around Bitgo Holdings has focused on its role in digital asset custody and broader crypto market...
NasdaqGM:CAN
NasdaqGM:CANTech

A Look At Canaan (NasdaqGM:CAN) Valuation After Earnings, 2026 Guidance And January Bitcoin Production Update

Why Canaan’s latest numbers matter for shareholders Canaan (NasdaqGM:CAN) just released fourth quarter and full year 2025 results, fresh earnings guidance for the first quarter of 2026, and January Bitcoin production data, giving investors several new reference points to assess the stock. For the fourth quarter ended December 31, 2025, Canaan reported revenue of US$196.27 million, compared with US$88.77 million a year earlier. The company recorded a net loss of US$85.04 million for the...
NYSE:CRL
NYSE:CRLLife Sciences

New Charles River Leaders May Shape Valuation, Debt And Governance Outlook

Charles River Laboratories International (NYSE:CRL) has appointed Glenn G. Coleman as Chief Financial Officer. The company has also named Kerry Dailey as Chief Legal Officer, expanding its senior leadership bench. These leadership changes are aimed at reinforcing financial oversight, legal governance, and corporate compliance. Charles River Laboratories operates as a key partner for pharmaceutical and biotech companies, supporting drug discovery, preclinical research, and related services...
NYSE:BCO
NYSE:BCOCommercial Services

Did Brink’s Operations Veteran Appointment to Lead North America Just Shift Brink's (BCO) Investment Narrative?

The Brink’s Company has appointed Adrian Button as executive vice president and president of Brink’s North America, effective February 16, 2026, adding him to the executive leadership team reporting to CEO Mark Eubanks. With more than 30 years of global operational leadership at GE, NCR, and Carrier overseeing multibillion-dollar businesses and large-scale supply chains, Button’s background directly aligns with Brink’s focus on operational efficiency and service quality in North...